CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

CMG Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019	Dec 31, 2018
Market Capitalization	291,840	245,561	334,730	298,618	590,292	461,137
Market Cap Growth	20.76%	-26.64%	12.09%	-49.41%	28.01%	-32.13%
Enterprise Value	322,652	239,371	285,069	182,746	466,997	406,460
Last Close Price	1974.00	1768.00	2410.00	2150.00	4250.00	3945.03
PE Ratio	-	91.13	51.85	-	193.46	76.03
PS Ratio	2.91	2.48	3.56	3.63	10.07	9.25
PB Ratio	1.43	1.30	1.76	1.62	3.28	4.43
P/TBV Ratio	1.47	1.33	1.82	1.64	3.30	4.48
P/OCF Ratio	-	846.50	84.99	60.48	209.07	520.01
EV/Sales Ratio	3.21	2.42	3.04	2.22	7.97	8.15
EV/EBITDA Ratio	-	54.82	50.96	34.71	99.16	92.05
EV/EBIT Ratio	-	234.60	93.87	61.30	179.35	158.17
EV/FCF Ratio	-9.08	-	-	-	-	-
Debt / Equity Ratio	0.35	0.42	0.14	0.04	0.00	-
Debt / EBITDA Ratio	-	18.31	4.67	1.27	0.06	-
Net Debt / Equity Ratio	0.15	0.02	-0.22	-0.38	-0.66	-0.52
Net Debt / EBITDA Ratio	-29.67	0.73	-7.63	-13.50	-25.33	-12.33
Net Debt / FCF Ratio	-0.87	-0.11	5.06	20.64	22.29	32.83
Asset Turnover	0.33	0.36	0.41	-	0.38	0.45
Inventory Turnover	1.73	2.41	2.40	-	3.38	3.30
Quick Ratio	0.72	3.47	3.80	4.58	15.12	8.50
Current Ratio	1.08	4.29	4.72	6.17	16.18	9.58
Return on Equity (ROE)	-4.79%	1.42%	3.44%	-	2.15%	6.01%
Return on Assets (ROA)	-0.87%	0.23%	0.83%	-	1.06%	1.43%
Return on Invested Capital (ROIC)	-1.94%	0.56%	2.23%	3.41%	3.74%	5.68%
Return on Capital Employed (ROCE)	-2.10%	0.40%	1.40%	1.60%	1.40%	2.40%
Earnings Yield	-3.29%	1.10%	1.93%	-0.13%	0.52%	1.31%
FCF Yield	-12.18%	-11.32%	-2.52%	-1.15%	-0.91%	-0.36%
Payout Ratio	-	-	0.45%	-	-	-
Buyback Yield / Dilution	16.18%	-13.12%	-	-14.27%	-11.63%	0.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.